Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Alzheimer’s Breakthrough: Why the Experts are Betting on NervGen

It's the disease that most of us regard with the greatest dread – especially since nearly one in every three people will eventually be afflicted. This is why a breakthrough pharmaceutical drug for Alzheimer’s disease would not only be a godsend to society,...

Pandemic fears: real and imagined

“Pandemic”. Few words in the English language conjure as much fear. The mere utterance evokes images of dying patients, surgical masks, haz-mat suits, a parade of coffins, helpless doctors and nurses, as the contagion spreads, first striking down the el...

Canadian mining, oil & gas have a lot to lose from minority government

In mid-August, a ground-breaking ceremony of sorts took place in Edmonton for the Trans Mountain Pipeline project . Natural Resources Minister Amarjeet Sohi picked the yard of pipeline contractor SA Energy to announce that Trans Mountain Corp. is moving forward to constr...

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....

GBP/USD – Pound in Holding Pattern Ahead of British GDP, Manufacturing Production

Kenny Fisher GBP/USD is showing little movement for a fifth straight day. Currently, the pair is trading at 1.3155, up 0.07% on the day. All Eyes on British GDP, Mfg. Production Investors are keeping a close eye on the monthly GDP report....

GBP/USD – Pound Gaining Ground as Boris Holds Lead in Polls

It’s Election Day across the U.K, and millions of voters will determine what happens next with the Brexit saga, which has lasted three years. If Prime Minister Johnson can win an outright majority, the British pound could respond with significant gains. ...

Ely Gold's New Option/Royalty Model Provides Opportunities

This company is transforming the model for mineral exploration in the Western United States. Ely Gold Royalties Inc. (ELY:TSX.V; ELYGF:OTCQB) has turned the parameters and expectations of a typical project generator around by substituting the traditional joint venture b...

Gold Market Update: Metal Up, Dollar Down

Technical expert Clive Maund charts the reasons the precious metals have entered a bull market. Gold is now a major bull market, as evidenced by its strong breakout from a giant 6-year long base pattern in August. The larger trend is up. We had thought that it might r...

The Great Dichotomy

One of the advantages of being a sexagenarian is that after forty years investing in stocks, bonds, commodities, and currencies you have a pretty good idea when something is not exactly "right." If you have lived a good, normal life and you still have decent control of ov...
1 2 3 4